SCHEMBL30362791

SCHEMBL30362791

COc1ccnc(C(N)=O)c1-c1ccc[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 3/20 0.40
▸ CHUK O15111 2/20 0.40
▸ KDM4C Q9H3R0 1/20 0.39
▸ CYP1A1 P04798 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ TGFBR1 P36897 1/20 0.36
▸ CDC7 O00311 1/20 0.36
▸ TUBB4A P04350 1/20 0.36
▸ TUBB P07437 1/20 0.36
▸ TUBA3C P0DPH7 1/20 0.36
▸ TUBA1B P68363 1/20 0.36
▸ TUBA4A P68366 1/20 0.36
▸ TUBB4B P68371 1/20 0.36
▸ TUBB3 Q13509 1/20 0.36
▸ TUBB2A Q13885 1/20 0.36
▸ TUBB8 Q3ZCM7 1/20 0.36
▸ TUBA3E Q6PEY2 1/20 0.36
▸ TUBA1A Q71U36 1/20 0.36
▸ TUBA1C Q9BQE3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30362795 0.78 KDM4C (0.39) IKBKBCHUKKDM4CTGFBR1TUBB4A
SCHEMBL19949454 0.77 IKBKB (0.39) IKBKBCHUKKDM4CFYNMAPK8
SCHEMBL30362954 0.76 KDM4E (0.40) IKBKBCHUKKDM4CTGFBR1CDC7
SCHEMBL18076065 0.73 MKNK1 (0.49) IKBKBCHUKFYNINSRMAPK8
SCHEMBL19949295 0.73 PLAU (0.48) IKBKBCHUKTUBB4ATUBBTUBA3C
SCHEMBL28804353 0.72 CDK5 (0.43) KDM4CTGFBR1L3MBTL1
SCHEMBL30665045 0.72 CDK5 (0.43) KDM4CTGFBR1L3MBTL1
SCHEMBL30363113 0.71 KDM4C (0.42) IKBKBCHUKKDM4CTGFBR1CDC7
SCHEMBL21855442 0.71 IKBKB (0.54) IKBKBKDM4CAPAF1NSD2CASP3
SCHEMBL14308482 0.71 IKBKB (0.47) IKBKBPLAUAPAF1NSD2CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114127080-B Heterocyclic compounds as kinase inhibitors, compositions comprising the same, and methods of use thereof 捷思英达医药技术(上海)有限公司 2023-05-05 — — CN claimed
CN-114127080-B Heterocyclic compounds as kinase inhibitors, compositions comprising the same, and methods of use thereof 捷思英达医药技术(上海)有限公司 2023-05-05 — — CN disclosed
Send feedback